Literature DB >> 8252473

Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis.

E Adachi1, T Matsumata, T Nishizaki, H Hashimoto, M Tsuneyoshi, K Sugimachi.   

Abstract

BACKGROUND: The effects of preoperative transcatheter arterial chemoembolization (TAE) for hepatocellular carcinoma (HCC) remain a matter of controversy.
METHODS: Seventy-two patients with HCC were entered in the study; the patients did not have the risk factors for disease recurrence of tumor larger than 5 cm in diameter, the presence of venous invasion, or intrahepatic metastasis. Only patients with 3 years of follow-up after curative resection were selected. Forty-six underwent TAE (Group I) and 26 did not undergo TAE (Group II). Group I was divided into three subgroups according to the degree of tumor necrosis: IA, complete necrosis; IB, partial necrosis; and IC, no necrosis. Group II was divided into two subgroups: IIB, partial necrosis; and IIC, no necrosis.
RESULTS: Preoperative TAE did not improve the average disease-free survival rates of the group as a whole. For patients undergoing TAE, the survival rate of Group IB was significantly worse than that of Groups IA or IC. The survival rate of Group IB was worse than that of Group II, but the difference was not significant. In Group II, the survival of Group IIB was worse than that of Group IIC. Histologically, residual tumor cells lacking mutual contact were detected in some patients in Group IB.
CONCLUSION: These results indicate that partial tumor necrosis caused by preoperative TAE or spontaneous tumor necrosis per se might facilitate postoperative disease recurrence. This may occur because in patients with partial necrosis, the remaining tumor cells are less firmly attached and more likely to be dislodged into the bloodstream during hepatic resection.

Entities:  

Mesh:

Year:  1993        PMID: 8252473     DOI: 10.1002/1097-0142(19931215)72:12<3593::aid-cncr2820721208>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.

Authors:  Do Young Kim; Moon Seok Choi; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Sung Wook Shin; Sung Wook Choo; Young Soo Do; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

2.  Preliminary study of apparent diffusion coefficient assessment after ion beam therapy for hepatocellular carcinoma.

Authors:  Masayuki Kanamoto; Tosiaki Miyati; Kazuki Terashima; Daisaku Suga; Nobukazu Fuwa
Journal:  Radiol Phys Technol       Date:  2016-04-07

Review 3.  Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects.

Authors:  S E Cohen; R Safadi; A Verstandig; A Eid; T Sasson; L Symmer; D Shouval
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

4.  The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Masataka Amisaki; Soichiro Honjo; Masaki Morimoto; Takehiko Hanaki; Yosuke Arai; Naruo Tokuyasu; Teruhisa Sakamoto; Yasufumi Ohuchi; Hiroaki Saito
Journal:  Yonago Acta Med       Date:  2016-12-26       Impact factor: 1.641

5.  The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization.

Authors:  Tadaaki Arizumi; Kazuomi Ueshima; Mina Iwanishi; Tomohiro Minami; Hirokazu Chishina; Masashi Kono; Masahiro Takita; Norihisa Yada; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida; Yoriaki Komeda; Mamoru Takenaka; Toshiharu Sakurai; Tomohiro Watanabe; Naoshi Nishida; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-05-09       Impact factor: 11.740

6.  Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization.

Authors:  Stéphane Zalinski; Olivier Scatton; Bruto Randone; Olivier Vignaux; Bertrand Dousset
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

7.  Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence.

Authors:  Hiroyuki Sugo; Shunji Futagawa; Tomoe Beppu; Masaki Fukasawa; Kuniaki Kojima
Journal:  World J Surg       Date:  2003-11-05       Impact factor: 3.352

8.  Preresection transarterial chemoembolization for hepatocellular carcinoma: an experience with 23 patients.

Authors:  Mahesh Goel; Vinay Gaikwad; Tejas Dharia; Suyash Kulkarni; Nitin Shetty; Shailesh V Shrikhande
Journal:  Indian J Gastroenterol       Date:  2014-07-19

9.  Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.

Authors:  Marine Gross-Goupil; Raphaël Saffroy; Daniel Azoulay; Sophie Precetti; Jean-François Emile; Valérie Delvart; Fréderic Tindilière; Alexis Laurent; Marie-France Bellin; Henri Bismuth; Brigitte Debuire; Antoinette Lemoine
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

10.  Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?

Authors:  Gi-Hong Choi; Dong-Hyun Kim; Chang-Moo Kang; Kyung-Sik Kim; Jin-Sub Choi; Woo-Jung Lee; Byong-Ro Kim
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.